MEDIPAN GMBH has a total of 20 patent applications. Its first patent ever was published in 2008. It filed its patents most often in EPO (European Patent Office), China and Australia. Its main competitors in its focus markets measurement, pharmaceuticals and environmental technology are ATTO BIOSCIENCE INC, HESS HARALD F and NEGEVTECH LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | China | 4 | |
#3 | Australia | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Canada | 2 | |
#6 | United States | 2 | |
#7 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Pharmaceuticals | |
#3 | Environmental technology | |
#4 | Optics |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Medical preparations | |
#3 | Climate change adaptation technologies | |
#4 | Optical systems |
# | Name | Total Patents |
---|---|---|
#1 | Roggenbuck Dirk | 12 |
#2 | Hiemann Rico | 6 |
#3 | Radau Boris | 4 |
#4 | Arndt Matthias | 3 |
#5 | Knutter Ilka | 2 |
#6 | Roggenbuck Dirk Dr | 1 |
#7 | Knuetter Ilka Dr | 1 |
#8 | Knütter Ilka | 1 |
#9 | Knuetter Ilka I | 1 |
#10 | Knuetter Ilka | 1 |
Publication | Filing date | Title |
---|---|---|
US2021033840A1 | Xyz microscope stage with a vertically translatable carriage | |
CA2837253A1 | Methods and system for the automated determination of immunofluorescent foci using a cell-based immunofluorescence assay using synthetic calibration particles | |
EP2362222A1 | Method and device for the simultaneous detection of antibodies bound to synthetic and cellular and/or tissue substrates | |
WO2009062497A2 | Method for end-titre determination and the evaluation thereof by means of an indirect immunofluorescence assay |